Autopsy report · NCT03081117
Intranasal Insulin for the Treatment of HAND
Cause of deathStaffing, sites or logistics, also safety
“On 3/15/2020 study visits were suspended due to COVID-19 pandemic. With safety concerns surrounding COVID-19 and difficulty recruiting, the investigators decided to close enrollment 10/16/2020 after interim data were reviewed by the DSMB and NIH.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 3 years 2 months before it stopped.
- 21 participants enrolled.
- Results were posted on the registry 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Johns Hopkins University
- Sponsor type
- University, hospital or other
- Conditions
- HIV Dementia; HIV-Associated Cognitive Motor Complex
- Interventions
- Insulin, intranasal; Placebo, intranasal
- Participants
- 21
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Emory Latino Diabetes Education Program
“Enrollment and study activities were suspended in March 2020 due to the COVID-19 pandemic and re-opening the study was delayed pending additional funding. The study was ultimately terminated in January of 2026 due to lack of funding.” - A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)
“Study was suspended in 2020 due to COVID-19 pandemic as a result of recruitment challenges and the inability to conduct all study procedures (e.g., bronchoscopy) per protocol. In late 2021 the decision was made to not re-open the study.” - Impact of Cigarette and E-cigarette Flavors on Adult Smoking Behavior
“Study enrollment was temporarily paused in 2020 due to COVID-19. Study was closed without further enrollment in 2022.” - A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)
“Study initially suspended due to COVID-19 Pandemic- treatment stopped - never reopened to recruitment..” - Improving Health Behaviors for Pediatric Cancer Survivors
“Study recruitment of new participants was suspended during 2020 due to the Covid-19 pandemic.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.